Latest News & Features
Americas
The US pharma giant is spending up to $1 billion to build an end-to-end biosimilar platform and is counting on a decade of expiring biologic patents to make it pay off. 23 April 2026
Americas
Plaintiff alleges that a $6 billion rival probed its records system via a long-term customer, using confidential information to develop its product in the behavioural health tech space. 23 April 2026
Americas
Decision underscores a growing deference to parallel rulings and tighter control over duplicate patent challenges. 22 April 2026
Careers
A New Jersey firm appoints the high-stakes litigator as chair of its trademarks, trade secrets and copyright practice, bringing experience across patent, trade secret, trademark, trade dress, and copyright disputes. 21 April 2026
Europe
With the start of the first-ever INTA Annual Meeting held in the UK capital just weeks away, in-house IP counsel share their favourite ways to spend downtime in the city. 21 April 2026
Americas
The maker of a cosmetic penile implant has suffered at the Federal Circuit, after a ruling said its trade secrets claims are not protectable while leaving a counterfeiting finding intact. 20 April 2026
Americas
A ruling that invalidated three of Teva's headache treatment patents has been thrown out, sending a long-running case back to the lower court. 17 April 2026
Careers
The Hong Kong partner brings more than 20 years’ experience and specialises in trademark strategy, cross-border enforcement, and brand protection across Asia and beyond. 17 April 2026
Careers
Fresh hire, who will take up his new role in May, brings years of expertise in pharmaceuticals and artificial intelligence to the firm’s Frankfurt practice. 16 April 2026
Americas
The Cambridge biotech is accused of infringing six patents covering technologies used to target drug-resistant cancer mutations. 16 April 2026